opc 12759 and Graft vs Host Disease studies

opc 12759 and Graft vs Host Disease

rebamipide: structure in first source; RN refers to (+-)-isomer; inhibits gastric xanthine oxidase

Graft vs Host Disease: The clinical entity characterized by anorexia, diarrhea, loss of hair, leukopenia, thrombocytopenia, growth retardation, and eventual death brought about by the GRAFT VS HOST REACTION.

Research Excerpts

Excerpt	Relevance	Reference
"Long-term treatment with topical rebamipide and diquafosol can improve dry eye in patients with cGVHD or OCP-like disease."	7.81	Long-term rebamipide and diquafosol in two cases of immune-mediated dry eye. ( Fukui, M; Kamoi, M; Kawakita, T; Mukai, S; Ogawa, Y; Saijo-Ban, Y; Simmura, S; Tsubota, K; Yaguchi, S; Yamane, M, 2015)
"Long-term treatment with topical rebamipide and diquafosol can improve dry eye in patients with cGVHD or OCP-like disease."	3.81	Long-term rebamipide and diquafosol in two cases of immune-mediated dry eye. ( Fukui, M; Kamoi, M; Kawakita, T; Mukai, S; Ogawa, Y; Saijo-Ban, Y; Simmura, S; Tsubota, K; Yaguchi, S; Yamane, M, 2015)

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Timeframe

Studies, this research(%)

All Research%

pre-1990

0 (0.00)

18.7374

1990's

0 (0.00)

18.2507

2000's

0 (0.00)

29.6817

2010's

2 (100.00)

24.3611

2020's

0 (0.00)

2.80

Authors

Authors	Studies
Shamloo, K	1
Barbarino, A	1
Alfuraih, S	1
Sharma, A	1
Yamane, M	1
Ogawa, Y	1
Fukui, M	1
Kamoi, M	1
Saijo-Ban, Y	1
Yaguchi, S	1
Mukai, S	1
Kawakita, T	1
Simmura, S	1
Tsubota, K	1

Studies

Shamloo, K

Barbarino, A

Alfuraih, S

Sharma, A

Yamane, M

Ogawa, Y

Fukui, M

Kamoi, M

Saijo-Ban, Y

Yaguchi, S

Mukai, S

Kawakita, T

Simmura, S

Tsubota, K

Other Studies

2 other studies available for opc 12759 and Graft vs Host Disease

Article	Year
Graft Versus Host Disease-Associated Dry Eye: Role of Ocular Surface Mucins and the Effect of Rebamipide, a Mucin Secretagogue. Investigative ophthalmology & visual science, 2019, 11-01, Volume: 60, Issue:14 Topics: Administration, Ophthalmic; Alanine; Animals; Antioxidants; Bone Marrow Transplantation; CA-125 Anti	2019
Long-term rebamipide and diquafosol in two cases of immune-mediated dry eye. Optometry and vision science : official publication of the American Academy of Optometry, 2015, Volume: 92, Issue:4 Suppl 1 Topics: Administration, Topical; Aged; Alanine; Drug Therapy, Combination; Dry Eye Syndromes; Enzyme Inhibit	2015

Article

Year

Graft Versus Host Disease-Associated Dry Eye: Role of Ocular Surface Mucins and the Effect of Rebamipide, a Mucin Secretagogue.

Investigative ophthalmology & visual science, 2019, 11-01, Volume: 60, Issue:14

Topics: Administration, Ophthalmic; Alanine; Animals; Antioxidants; Bone Marrow Transplantation; CA-125 Anti

2019

Long-term rebamipide and diquafosol in two cases of immune-mediated dry eye.

Optometry and vision science : official publication of the American Academy of Optometry, 2015, Volume: 92, Issue:4 Suppl 1

Topics: Administration, Topical; Aged; Alanine; Drug Therapy, Combination; Dry Eye Syndromes; Enzyme Inhibit

2015